(Sharecast News) - Data science and biostatistics company Physiomics said on Thursday that it has secured a "sizeable contract extension award" with an existing large pharmaceutical client.
Physiomics said the project builds upon the contract award announced on 13 June 2024, where its proprietary Virtual Tumour platform has been used to...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE